Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS24P16 (ribosomal protein S24 pseudogene 16) is a processed pseudogene derived from duplication of the RPS24 gene, which encodes ribosomal protein S24, a component of the 40S ribosomal subunit responsible for catalyzing protein synthesis[4][6]. Pseudogenes are nonfunctional sequences that closely resemble functional genes but lack the ability to encode a protein product. RPS24P16 does not contribute to ribosome function and has no known biological or disease role in humans. Unlike its functional counterpart RPS24, which is associated with ribosome biogenesis and implicated in Diamond-Blackfan anemia, RPS24P16 exists as part of the genomic landscape of pseudogenes found throughout the human genome. It is not considered a therapeutic target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S24 pseudogene 16 (RPS24P16).